Contact information
BIOGRAPHY
Chris Butler studied medicine at Gonville and Caius College, Cambridge (1991-1994) and then at the University of Edinburgh (1994-1997). He conducted his PhD on the syndrome of transient epileptic amnesia under the supervision of Professor Adam Zeman. He worked as a post-doctoral fellow at the Memory and Aging Center, University of California at San Francisco and moved to Oxford in 2009. He was awarded a Clinician Scientist fellowship from the Medical Research Council in 2013.
Training and qualifications
- PhD (Edin) 2009
- MSc (Edin) in Philosophy of Mind 2009
- MRCP (UK) 2001
- MB ChB (Edin) 1997
- MA (Cantab) 1995
Christopher Butler
PhD FRCP Edin
Associate Professor
RESEARCH SUMMARY
Memory loss is a disabling consequence of many common neurological disorders including dementia, stroke, epilepsy and head injury. A central goal of cognitive neuroscience is therefore to understand the relationships between memory and brain function, both in health and disease.
My research focusses on understanding the memory deficits experienced by patients with damage to the medial temporal lobes of the brain due to:
- limbic encephalitis
- epilepsy
- Alzheimer's disease
Sources of funding
- John Fell Fund (2017-2018)
- MRC (2015-2020)
- ARUK (2017-2018)
- MRC (2013-2018)
- NIHR (2009-2013)
- Wellcome Trust (2010-2013)
- Epilepsy Research UK (2010-2013)
Research groups
Recent publications
-
Proteomic analysis reveals distinct cerebrospinal fluid signatures across genetic frontotemporal dementia subtypes.
Journal article
Sogorb-Esteve A. et al, (2025), Sci Transl Med, 17
-
Hippocampal damage disrupts the latent decision-making processes underlying approach-avoidance conflict processing in humans
Journal article
Le Duc W. et al, (2025), PLoS Biology, 23
-
Performance and validation of a digital memory test across the Alzheimer's disease continuum.
Journal article
Toniolo S. et al, (2025), Brain Commun, 7
-
Association of Changes in Cerebral and Hypothalamic Structure With Sleep Dysfunction in Patients With Genetic Frontotemporal Dementia.
Journal article
Best PT. et al, (2024), Neurology, 103
-
Association of Initial Side of Brain Atrophy With Clinical Features and Disease Progression in Patients With GRN Frontotemporal Dementia.
Journal article
Borrego-Ecija S. et al, (2024), Neurology, 103
-
Correction to: Remote focused encoding and decoding of electric fields through acoustoelectric heterodyning (Communications Physics, (2023), 6, 1, (79), 10.1038/s42005-023-01198-w)
Journal article
Rintoul JL. et al, (2024), Communications Physics, 7
-
Inflammatory plasma profile in genetic symptomatic and presymptomatic Frontotemporal Dementia - A GENFI study.
Journal article
Fenoglio C. et al, (2024), Brain Behav Immun, 122, 231 - 240
-
Safety, tolerability, and efficacy outcomes of the Investigation of Levetiracetam in Alzheimer's disease (ILiAD) study: a pilot, double-blind placebo-controlled crossover trial.
Journal article
Sen A. et al, (2024), Epilepsia Open
-
NfL reliability across laboratories, stage-dependent diagnostic performance and matrix comparability in genetic FTD: a large GENFI study.
Journal article
Linnemann C. et al, (2024), J Neurol Neurosurg Psychiatry, 95, 822 - 828
-
[Not Available].
Journal article
Pasternak M. et al, (2024), Alzheimers Dement, 20, 3525 - 3542